Novel PCSK9 Inhibitor Lowers Lipids Across the Board Novel PCSK9 Inhibitor Lowers Lipids Across the Board

Blocking PCSK9 synthesis via RNA interference with inclisiran significantly reduces atherogenic lipoproteins in addition to the results seen with LDL cholesterol, secondary ORION 1 analysis shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news